tocilizumab,obinutuzumab,glofitamab
jw pharma,roche
['dlbcl', 'congrat', 'kudos', 'glofitamab', 'genentech']
great news! #17icml glofitamab approved for r/r dlbcl after 2 lines of therapy congrats for his leadership of many of the clinical trials needed to get to this accelerated approval and kudos to for a fixed duration regimen 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem